• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Global Variations in Blood Safety and Availability Based on WHO Report

January 24, 2018

Every two years since 1998 the World Health Organization (WHO) has collected data on blood safety and availability. The WHO 2016 global status report contains data from 180 countries, representing 98.3% of the world’s population.  Worldwide, over 112 million blood donations were collected during the 2013 survey, but blood availability and safety were found to vary by region and income group.  For example, 47% of blood donations were collected from high income countries with 19% of the global population.  In addition, blood donations from repeat donors varied widely from less than 0.1% to 100% (median 45%); low and middle income countries tended to lack repeat donors and had higher rates of discarded blood.  Significant differences in blood use were also found based on income.  In higher income countries, 79% of transfusions were for supportive care during surgeries, trauma, or therapy for cancers.  In low-and-middle-income countries, 67% of transfusions were for children under 5 years old, followed by transfusions for women due to pregnancy-related complications.  The report concludes that governments and partners need to “scale up efforts in implementing the WHO blood safety strategies and improving the safe and sufficient supply of blood and blood products throughout the world.”

Reference:

Global status report on blood safety and availability 2016. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.   Accessed online January 23, 2018

Filed Under

  • Blood Donation
  • News
  • Policy and Guidelines
  • RBC Transfusion

Recommended

  • Randomized Trial of Platelet Transfusions and Risk of Bleeding before CVC Placement

  • Traditional Chinese Herbs Not Effective for Intracerebral Hemorrhage: A Randomized Trial

  • Donor, Blood Component, and Patient Factors all Affect Hemoglobin Levels after RBC Transfusion

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley